Mesalamine 0.375gm Capsules
Overview
What is this medicine?
How to Use This Medicine
To get the most benefit from your medication, follow your doctor's instructions carefully. Read all the information provided with your prescription and follow the instructions closely. You can take this medication with or without food, but be sure to swallow it whole with a full glass of water. Do not chew, open, or crush the medication. If you have difficulty swallowing, consult your doctor for guidance.
Continue taking your medication as directed by your doctor or healthcare provider, even if you start to feel better. However, do not take antacids at the same time as this medication. If you need to take antacids, talk to your doctor about the best timing.
Storing and Disposing of Your Medication
Store your medication at room temperature in a dry place, avoiding the bathroom. Some products may come with a desiccant (a moisture-protecting packet) in the container. If your container has a desiccant, keep it in the bottle. If you're unsure about storing your medication without the desiccant, consult your doctor or pharmacist. Keep all medications in a safe place, out of the reach of children and pets.
What to Do If You Miss a Dose
If you miss a dose, take it as soon as you remember. However, if it's close to the time for your next scheduled dose, skip the missed dose and resume your regular dosing schedule. Do not take two doses at the same time or take extra doses to make up for a missed dose.
Lifestyle & Tips
- Take Apriso capsules whole with food, once daily. Do not crush, chew, or break the capsules.
- Take the medication consistently as prescribed, even if you feel better, to maintain remission.
- Stay well-hydrated, especially if you experience diarrhea.
- Report any new or worsening symptoms to your doctor, including changes in urine output, yellowing of skin/eyes, unexplained bleeding/bruising, or severe abdominal pain.
- Avoid taking antacids or other medications that significantly alter stomach pH around the same time as Apriso, as this could affect its release.
Available Forms & Alternatives
Available Strengths:
- Mesalamine Rectal Susp 28x60ml
- Mesalamine Rectal Susp 7x60ml
- Mesalamine 4gm Kit( 7 X 60ml)
- Mesalamine 4gm Kit (4 Kits)
- Mesalamine 800mg DR Tablets
- Mesalamine 400mg DR Capsules
- Mesalamine 1000mg Suppositories
- Mesalamine 1.2gm Tablets
- Mesalamine 0.375gm Capsules
- Mesalamine 0.375gm ER Capsules
- Mesalamine 500mg ER Capsules
- Mesalamine 0.375gm Capsules
- Mesalamine Rectal Susp 7x60ml
- Mesalamine Rectal Susp 28x60ml
- Mesalamine 800mg DR Tablets
Dosing & Administration
Adult Dosing
Condition-Specific Dosing:
Pediatric Dosing
Dose Adjustments
Renal Impairment:
Hepatic Impairment:
Pharmacology
Mechanism of Action
Pharmacokinetics
Absorption:
Distribution:
Elimination:
Pharmacodynamics
Safety & Warnings
Side Effects
Although rare, some people may experience severe and potentially life-threatening side effects while taking this medication. If you notice any of the following symptoms, contact your doctor immediately or seek emergency medical attention:
Signs of an allergic reaction, such as:
+ Rash or hives
+ Itching or red, swollen, blistered, or peeling skin (with or without fever)
+ Wheezing or tightness in the chest or throat
+ Difficulty breathing, swallowing, or talking
+ Unusual hoarseness or swelling of the mouth, face, lips, tongue, or throat
Signs of kidney problems, including:
+ Inability to urinate or changes in urine output
+ Blood in the urine or significant weight gain
+ Back pain, abdominal pain, or blood in the urine (which may indicate a kidney stone)
Chest pain or pressure, rapid or irregular heartbeat
Fever, chills, sore throat, unexplained bruising or bleeding, or feeling extremely tired or weak
Symptoms that may resemble ulcerative colitis, such as:
+ New or worsening stomach pain or cramps
+ Bloody stools
+ Fever
+ Headache
+ Itching or rash
+ Red or pink eyes
+ General feeling of illness
Signs of liver problems, which can be rare but potentially life-threatening:
+ Dark urine
+ Fatigue
+ Decreased appetite
+ Upset stomach or stomach pain
+ Light-colored stools
+ Vomiting
+ Yellow skin or eyes
Signs of heart problems, which can be rare but potentially life-threatening:
+ Shortness of breath
+ Significant weight gain
+ Swelling in the arms or legs
Severe skin reactions, including:
+ Stevens-Johnson syndrome (SJS)
+ Toxic epidermal necrolysis (TEN)
+ Other serious reactions that can affect skin and organs
+ Symptoms may include:
- Red, swollen, blistered, or peeling skin
- Red or irritated eyes
- Sores in the mouth, throat, nose, eyes, genitals, or skin
- Fever
- Chills
- Body aches
- Shortness of breath
- Swollen glands
Other Possible Side Effects
Like all medications, this drug can cause side effects. Many people experience no side effects or only mild ones. However, if you notice any of the following side effects or if they persist or bother you, contact your doctor:
Constipation
Diarrhea
Stomach pain or upset stomach
Vomiting
Heartburn
Gas
Burping
Nose or throat irritation
Dizziness or headache
Back pain
* Cough
This is not an exhaustive list of possible side effects. If you have questions or concerns about side effects, consult your doctor. You can also report side effects to the FDA at 1-800-332-1088 or online at https://www.fda.gov/medwatch.
Seek Immediate Medical Attention If You Experience:
- Severe abdominal pain, cramping, or bloody diarrhea (may indicate acute intolerance syndrome or worsening UC)
- Signs of kidney problems: decreased urination, swelling in feet/ankles, unusual tiredness
- Signs of liver problems: yellowing of skin or eyes (jaundice), dark urine, persistent nausea/vomiting, severe stomach pain
- Signs of pancreatitis: severe pain in your upper stomach spreading to your back, nausea, vomiting
- Signs of heart inflammation (myocarditis/pericarditis): chest pain, shortness of breath, palpitations
- Signs of blood problems: unusual bleeding or bruising, fever, sore throat, fatigue
- New or worsening skin rash, fever, or swollen lymph nodes (may indicate drug reaction with eosinophilia and systemic symptoms - DRESS syndrome)
Before Using This Medicine
It is essential to inform your doctor about the following:
Any allergies you have, including allergies to this medication, its components, or other substances, such as foods or drugs. Be sure to describe the symptoms you experienced.
Certain health conditions, including:
+ Kidney disease or liver disease
+ Stomach or bowel ulcers
+ Narrowing of the stomach valve or other types of stomach blockages
+ Blockages in the urinary tract (consult with your healthcare provider if you have this condition)
This list is not exhaustive, and it is crucial to discuss all your medications (prescription, over-the-counter, natural products, and vitamins) and health problems with your doctor and pharmacist. They will help determine if it is safe to take this medication with your existing health conditions and medications.
Remember, do not start, stop, or change the dose of any medication without first consulting your doctor.
Precautions & Cautions
This medication may interfere with certain laboratory tests, so it is crucial to notify all your healthcare providers and laboratory personnel that you are taking this drug.
To stay hydrated, drink plenty of non-caffeinated fluids, unless your doctor advises you to limit your fluid intake.
If you have phenylketonuria (PKU), consult with your doctor before taking this medication, as some products may contain phenylalanine.
While taking this medication, you may notice that your urine turns reddish-brown when it comes into contact with surfaces or water that have been treated with bleach, such as in the toilet. However, if you notice that your urine is reddish-brown before it comes into contact with any surfaces or water, contact your doctor.
You may be more susceptible to sunburn while taking this medication. To protect yourself, avoid exposure to the sun, sunlamps, and tanning beds, and use sunscreen and wear protective clothing and eyewear when going outside.
If you are 65 years or older, use this medication with caution, as you may be more prone to side effects.
Not all formulations of this medication are suitable for children. Before giving this medication to a child, consult with your doctor to determine the appropriate dosage and potential risks.
Do not give this medication to children or teenagers who have or are recovering from flu symptoms, chickenpox, or other viral infections, as it may increase the risk of Reye's syndrome, a condition that can cause severe brain and liver damage.
If you are pregnant, plan to become pregnant, or are breastfeeding, inform your doctor, as they will need to discuss the potential benefits and risks of this medication with you and determine the best course of action for you and your baby.
Overdose Information
Overdose Symptoms:
- Nausea
- Vomiting
- Abdominal pain
- Headache
- Drowsiness
- Vertigo
- Tinnitus
- Confusion
- Hyperventilation (rare, but possible with very high doses)
What to Do:
In case of suspected overdose, seek immediate medical attention or call a Poison Control Center (1-800-222-1222). Treatment is generally supportive and symptomatic. There is no specific antidote.
Drug Interactions
Major Interactions
- Azathioprine
- Mercaptopurine (6-MP)
Moderate Interactions
- Nonsteroidal Anti-inflammatory Drugs (NSAIDs)
- Nephrotoxic agents (e.g., tacrolimus, cyclosporine, aminoglycosides)
- Lactulose (and other drugs that lower stool pH)
Monitoring
Baseline Monitoring
Rationale: To establish baseline and identify pre-existing renal impairment, as mesalamine can cause renal toxicity.
Timing: Prior to initiation of therapy
Rationale: To establish baseline and identify pre-existing hepatic impairment, as mesalamine can cause hepatotoxicity.
Timing: Prior to initiation of therapy
Rationale: To establish baseline, especially if co-administering with thiopurines (azathioprine, mercaptopurine) due to increased risk of myelosuppression.
Timing: Prior to initiation of therapy
Routine Monitoring
Frequency: Annually, or more frequently if clinically indicated (e.g., in elderly, those with pre-existing renal disease, or on concomitant nephrotoxic drugs).
Target: Within normal limits or stable from baseline.
Action Threshold: Significant increase in creatinine or BUN; consider dose adjustment or discontinuation.
Frequency: Periodically, or if symptoms of hepatic dysfunction develop.
Target: Within normal limits or stable from baseline.
Action Threshold: Significant elevation; consider discontinuation.
Frequency: Periodically, especially if co-administered with azathioprine or mercaptopurine (e.g., every 3-6 months or as clinically indicated).
Target: Within normal limits.
Action Threshold: Significant decrease in white blood cell count, platelet count, or hemoglobin; consider discontinuation.
Symptom Monitoring
- Worsening of ulcerative colitis symptoms (e.g., increased frequency of bowel movements, rectal bleeding, abdominal pain)
- Signs of renal impairment (e.g., decreased urine output, swelling in ankles/feet, fatigue)
- Signs of hepatic impairment (e.g., yellowing of skin/eyes, dark urine, persistent nausea/vomiting, abdominal pain)
- Signs of hypersensitivity reactions (e.g., rash, fever, difficulty breathing, chest pain, pericarditis, myocarditis)
- Signs of acute intolerance syndrome (e.g., abdominal pain, cramping, bloody diarrhea, fever, headache, rash)
- Signs of pancreatitis (e.g., severe abdominal pain radiating to the back, nausea, vomiting)
- Signs of blood dyscrasias (e.g., unusual bruising or bleeding, persistent sore throat, fever, fatigue)
Special Patient Groups
Pregnancy
Mesalamine is generally considered low risk during pregnancy. Available data from published studies, postmarketing reports, and pregnancy registries over several decades have not identified a drug-associated risk of major birth defects, miscarriage, or adverse maternal or fetal outcomes. However, some studies suggest a potential for increased risk of preterm birth and low birth weight, though confounding factors are often present. Use only if clearly needed.
Trimester-Specific Risks:
Lactation
Mesalamine and its active metabolite (N-acetyl-5-ASA) are excreted in human milk in small amounts. While generally considered compatible with breastfeeding, monitor breastfed infants for signs of diarrhea. If diarrhea develops, discontinue breastfeeding or the drug.
Pediatric Use
Apriso is approved for the maintenance of remission of ulcerative colitis in pediatric patients 10 years of age and older. Safety and effectiveness have not been established in pediatric patients younger than 10 years of age.
Geriatric Use
No specific dose adjustments are required based on age alone. However, elderly patients are more likely to have decreased renal function, so monitoring of renal function is particularly important in this population. Use with caution in elderly patients with known or suspected renal impairment.
Clinical Information
Clinical Pearls
- Apriso is a delayed-release, extended-release formulation of mesalamine designed for once-daily dosing and targeted delivery to the colon. It must be taken with food.
- Patients should swallow the capsules whole and not crush, chew, or break them, as this will compromise the extended-release properties.
- Mesalamine can cause renal impairment, including interstitial nephritis. Regular monitoring of renal function is crucial, especially in patients with pre-existing renal disease, elderly patients, or those on concomitant nephrotoxic drugs.
- An acute intolerance syndrome resembling a flare of inflammatory bowel disease has been reported with mesalamine. Symptoms include cramping, acute abdominal pain, bloody diarrhea, fever, headache, and rash. If this occurs, discontinue therapy immediately.
- Caution is advised when co-administering mesalamine with azathioprine or mercaptopurine due to an increased risk of myelosuppression. Monitor CBC closely.
- Mesalamine can interfere with laboratory tests for normetanephrine, potentially leading to falsely elevated results.
Alternative Therapies
- Other oral mesalamine formulations (e.g., Lialda, Asacol HD, Pentasa, Delzicol)
- Rectal mesalamine formulations (e.g., Rowasa enema, Canasa suppositories)
- Corticosteroids (e.g., prednisone, budesonide)
- Immunomodulators (e.g., azathioprine, mercaptopurine, methotrexate)
- Biologic agents (e.g., infliximab, adalimumab, vedolizumab, ustekinumab)
- Janus kinase (JAK) inhibitors (e.g., tofacitinib, upadacitinib)